Ohio State Early Investor Network Disclaimer
OSEIN does not provide investment advice, and the information contained in this memo should not be solely relied upon for making investment decisions. Investors are encouraged to conduct their own due diligence and seek professional advice before making any investment. OSEIN does not assume any liability or responsibility for investment outcomes. Additionally, AI was used to review, synthesize, and prepare the following information.
Investing in early-stage and angel investments is inherently risky, and investors should be aware that they may lose their entire investment. By proceeding with any investment, investors acknowledge and assume these risks and understand that the outcomes can be unpredictable and may not result in financial gain.
Company: Construction Risk AI
Website: https://construction-risk-ai.com/
LinkedIn: https://www.linkedin.com/company/construction-risk-ai/about/
Venture 360: https://ohiostateearlyinvestornetwork.venture360.co/companies/139930-construction-risk-ai
Pitch Deck
Intake
Basic Company Information
- Company Name: Construction Risk AI
- Business Overview: Construction Risk AI is a vertical AI and data analytics company developing a standardized risk intelligence platform that aggregates fragmented construction data into a unified, actuarial-grade risk score for contractors and projects. By integrating data across ConTech systems, financial platforms, and job site operations, the company enables insurers, contractors, and owners to better assess performance, optimize underwriting, and reduce project risk. The company is initially targeting commercialization through insurance partnerships, positioning its platform as the industry’s first universal standard for construction risk assessment.
- Overall Raise: Construction Risk AI is currently raising up to $500K in a pre-seed round, structured as an equity investment with a target valuation cap of approximately $8M (negotiable). The company has been fully bootstrapped to date with no prior external funding. Proceeds from the raise are expected to support team expansion (engineering and go-to-market), product development, and execution of early insurance and contractor partnerships.
- Form of Business Entity: C Corporation
- Patent Status: Construction Risk AI’s technology is built on a proprietary intelligence engine that aggregates data from contractors’ tech stacks via APIs, standardizes it, and applies AI/ML to generate a standardized, actuarial-grade risk profile using 100+ KPIs. The company has not disclosed patent protection and instead relies on its proprietary models, data standardization process, and cross-platform data integration as its primary defensibility.
- Customer Base: Construction Risk AI’s customer base includes contractors, insurance companies, and ConTech firms, with owners/developers as key end users. Contractors use the platform to evaluate and benchmark project performance, insurers leverage it for underwriting and risk assessment, and ConTech companies use it to validate their impact on risk. The company’s primary go-to-market focus is on insurance companies, using them as a distribution channel to reach a broader network of contractors across the ecosystem.
- Revenue: Construction Risk AI has early revenue traction, with approximately $70K in signed contracts (accounts receivable) and potential to grow these to ~$180K. The company also reports a near-term pipeline of $300K–$400K+ in potential contracts, though these are not yet secured. To date, the company has been fully bootstrapped with no external funding. Its current and planned revenue model includes subscription-based pricing (~$5K/month for its dashboard) and per-report fees (~$2K per risk report), with expectations to scale through insurance partnerships and broader contractor adoption.
- Monthly Cash Burn Rate: Waiting for more information
Description
Scioto AgriTech has developed a proprietary cell-penetrating peptide delivery platform (MTDs) that enables biologically active molecules—such as nanobodies, proteins, and peptides—to cross plant cell membranes and reach intracellular targets. Unlike conventional biological crop protection methods, which are often limited by poor cellular uptake and require high application doses, Scioto’s approach facilitates direct intracellular delivery, significantly enhancing efficacy while reducing input requirements.